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For Astronaut Health During Long Term Spaceflight, Many 
Questions Remain
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• Immediate need to understand antibiotic resistance in microgravity
– Evidence that bacteria become more virulent and resistant than in normal gravity
– Astronaut’s immune system is compromised in microgravity
• Model Organism: uropathogenic Escherichia coli (UPEC)
– Urinary tract infections have been reported in astronauts
– WT and ΔrpoS mutant strains
– Gentamicin has been used to treat UTI
A History of Successful Bio NanoSats at Ames
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GeneSat-1 - 2006 PharmaSat- 2009 O/OREOS - 2010
EcAMSat – 2017
EcAMSat is First NASA 6U Mission
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• Passive magnetic orientation
• UHF Beacon and S-band radio
• Extensive thermal power management testing 
and modeling
• Mission Ops run by Santa Clara University
Experiment Design
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48 Well Fluidic Card
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• Alternating wells loaded with WT and mutant strains
• Each bank receives different antibiotic dose
Optical System Tracks Growth & Metabolic Activity
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Fluidic System Schematic
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EcAMSat Launch and Deployment
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• Launched on OA-8 mission – November 12, 2017
• Deployed from ISS on NanoRacks deployer – November 20, 2017
• Mission Ops conducted from Santa Clara University
Flight and Ground Experiment Optics Results
• The relative concentrations of the oxidized 
(Blue) and reduced (Pink) forms of 
AlamarBlue® are shown for Flight (top) 
and Ground (bottom). 
• The cell OD throughout the experiment is 
also shown (gray)
• Control bank shown suggests no large 
differences in timing between flight and 
ground and no difference in baseline 
stress between card load and experiment 
initiation
10
OD during growth phase
• Growth of single wells of WT and 
mutant in flight and ground
• Some wells in flight experienced a 
dip in OD while approaching 
stationary phase. Such wells were 
random and did not correlate to 
differences in AlamarBlue® 
reduction later in the experiment. 
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AlamarBlue® reduction after exposure to varied Gm concentrations
• AlamarBlue® reduction shown for 
wildtype and mutant strains at no, 
medium, and high concentrations 
of gentamicin in flight and ground
• Averages of all banks showed a 
combined effect of microgravity 
and gentimicin on reducing 
AlamarBlue® reduction in the 
medium dose exposure
• No significant difference seen in 
high dose banks
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Conclusions
• EcAMSat mission achieved full success, completing all required objectives. 
• While the various stresses imposed on the cells by the payload hardware, by the 
antibiotic, and due to microgravity could not be completely separated, it appeared that 
the effect of microgravity was greatest for both strains in the medium Gm dose case.
• The largest difference between the two strains was at the high dose. 
• The results demonstrate that the rpoS gene and its downstream products are important 
therapeutic targets for treating bacterial infections on Earth and in space.
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